207 related articles for article (PubMed ID: 7475173)
1. Studies of hypoxemic/reoxygenation injury: without aortic clamping. VII. Counteraction of oxidant damage by exogenous antioxidants: coenzyme Q10.
Morita K; Ihnken K; Buckberg GD; Young HH
J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 2):1221-7. PubMed ID: 7475173
[TBL] [Abstract][Full Text] [Related]
2. Studies of hypoxemic/reoxygenation injury: without aortic clamping. VI. Counteraction of oxidant damage by exogenous antioxidants: N-(2-mercaptopropionyl)-glycine and catalase.
Ihnken K; Morita K; Buckberg GD; Sherman MP; Young HH
J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 2):1212-20. PubMed ID: 7475172
[TBL] [Abstract][Full Text] [Related]
3. Studies of hypoxemic/reoxygenation injury: without aortic clamping. VIII. Counteraction of oxidant damage by exogenous glutamate and aspartate.
Morita K; Ihnken K; Buckberg GD; Matheis G; Sherman MP; Young HH
J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 2):1228-34. PubMed ID: 7475174
[TBL] [Abstract][Full Text] [Related]
4. Studies of hypoxemic/reoxygenation injury: with aortic clamping. XII. Delay of cardiac reoxygenation damage in the presence of cyanosis: a new concept of controlled cardiac reoxygenation.
Morita K; Ihnken K; Buckberg GD
J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 2):1265-73. PubMed ID: 7475178
[TBL] [Abstract][Full Text] [Related]
5. Studies of hypoxemic/reoxygenation injury: without aortic clamping. IX. Importance of avoiding perioperative hyperoxemia in the setting of previous cyanosis.
Morita K; Ihnken K; Buckberg GD; Sherman MP; Young HH
J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 2):1235-44. PubMed ID: 7475175
[TBL] [Abstract][Full Text] [Related]
6. Studies of hypoxemic/reoxygenation injury: without aortic clamping. IV. Role of the iron-catalyzed pathway: deferoxamine.
Morita K; Ihnken K; Buckberg GD; Sherman MP; Young HH
J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 2):1190-9. PubMed ID: 7475170
[TBL] [Abstract][Full Text] [Related]
7. Studies of hypoxemic/reoxygenation injury: without aortic clamping. III. Comparison of the magnitude of damage by hypoxemia/reoxygenation versus ischemia/reperfusion.
Ihnken K; Morita K; Buckberg GD; Sherman MP; Young HH
J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 2):1182-9. PubMed ID: 7475169
[TBL] [Abstract][Full Text] [Related]
8. Studies of hypoxemic/reoxygenation injury: without aortic clamping. II. Evidence for reoxygenation damage.
Ihnken K; Morita K; Buckberg GD; Matheis G; Sherman MP; Allen BS; Young HH
J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 2):1171-81. PubMed ID: 7475168
[TBL] [Abstract][Full Text] [Related]
9. Studies of hypoxemic/reoxygenation injury: without aortic clamping. V. Role of the L-arginine-nitric oxide pathway: the nitric oxide paradox.
Morita K; Sherman MP; Buckberg GD; Ihnken K; Matheis G; Young HH; Ignarro LJ
J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 2):1200-11. PubMed ID: 7475171
[TBL] [Abstract][Full Text] [Related]
10. Studies of hypoxemic/reoxygenation injury: with aortic clamping. X. Exogenous antioxidants to avoid nullification of the cardioprotective effects of blood cardioplegia.
Morita K; Ihnken K; Buckberg GD; Matheis G; Sherman MP; Young HH
J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 2):1245-54. PubMed ID: 7475176
[TBL] [Abstract][Full Text] [Related]
11. Studies of hypoxemic/reoxygenation injury with aortic clamping: XI. Cardiac advantages of normoxemic versus hyperoxemic management during qardiopulmonary bypass.
Ihnken K; Morita K; Buckberg GD; Young HH
J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 2):1255-64. PubMed ID: 7475177
[TBL] [Abstract][Full Text] [Related]
12. Studies of hypoxemic/reoxygenation injury: with aortic clamping. XIII. Interaction between oxygen tension and cardioplegic composition in limiting nitric oxide production and oxidant damage.
Ihnken K; Morita K; Buckberg GD; Sherman MP; Ignarro LJ; Young HH
J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 2):1274-86. PubMed ID: 7475179
[TBL] [Abstract][Full Text] [Related]
13. Reduced oxygen tension during cardiopulmonary bypass limits myocardial damage in acute hypoxic immature piglet hearts.
Ihnken K; Morita K; Buckberg GD; Winkelmann B; Beyersdorf F; Sherman MP
Eur J Cardiothorac Surg; 1996; 10(12):1127-34; discussion 1135. PubMed ID: 10369649
[TBL] [Abstract][Full Text] [Related]
14. Prevention of reoxygenation injury in hypoxaemic immature hearts by priming the extracorporeal circuit with antioxidants.
Ihnken K; Morita K; Buckberg GD; Ihnken O; Winkelmann B; Sherman M
Cardiovasc Surg; 1997 Dec; 5(6):608-19. PubMed ID: 9423947
[TBL] [Abstract][Full Text] [Related]
15. Nitric-oxide-induced reoxygenation injury in the cyanotic immature heart is prevented by controlling oxygen content during initial reoxygenation.
Ihnken K; Morita K; Buckberg GD; Winkelmann B; Schmitt M; Ignarro LJ; Sherman MP
Angiology; 1997 Mar; 48(3):189-202. PubMed ID: 9071194
[TBL] [Abstract][Full Text] [Related]
16. Delayed cardioplegic reoxygenation reduces reoxygenation injury in cyanotic immature hearts.
Ihnken K; Morita K; Buckberg GD
Ann Thorac Surg; 1998 Jul; 66(1):177-82. PubMed ID: 9692460
[TBL] [Abstract][Full Text] [Related]
17. Cardiopulmonary dysfunction produced by reoxygenation of immature hypoxemic animals supported by cardiopulmonary bypass. Prevention by intravenous metabolic pretreatment.
Matheis G; Tixier DB; Buckberg GD; Ihnken K; Morita K; Sherman MP; Young HH
J Thorac Cardiovasc Surg; 1993 Mar; 105(3):513-9. PubMed ID: 8095311
[TBL] [Abstract][Full Text] [Related]
18. Deep hypothermic circulatory arrest and global reperfusion injury: avoidance by making a pump prime reperfusate--a new concept.
Allen BS; Veluz JS; Buckberg GD; Aeberhard E; Ignarro LJ
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):625-32. PubMed ID: 12658205
[TBL] [Abstract][Full Text] [Related]
19. Prevention of the hypoxic reoxygenation injury with the use of a leukocyte-depleting filter.
Bolling KS; Halldorsson A; Allen BS; Rahman S; Wang T; Kronon M; Feinberg H
J Thorac Cardiovasc Surg; 1997 Jun; 113(6):1081-9; discussion 1089-90. PubMed ID: 9202689
[TBL] [Abstract][Full Text] [Related]
20. Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts.
Morita K; Ihnken K; Buckberg GD; Sherman MP; Young HH; Ignarro LJ
J Clin Invest; 1994 Jun; 93(6):2658-66. PubMed ID: 8201004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
